The pharmaceutical industry has reinforced its clout on Capitol Hill with campaign contributions that heavily support incumbents in both parties. That figure came to a total of $62.7 million during the 2016 election cycle, according to the OpenSecrets database.
The largest drug companies lean, in particular, toward the members of...
The pharmaceutical industry doesn’t just contribute to patient groups or the lawmakers themselves through campaign contributions to assert influence. It floods the U.S. Capitol with lobbyists.
A Tarbell analysis of lobbying disclosures found that the leading drugmakers that make up the Pharmaceutical Research and Manufacturers Association, and the association itself, have spent...